WellPoint’s technology will draw from libraries of evidence-based medical information, patient histories and test results, along with clinical expertise from Cedars-Sinai and other provider organizations, to present treatment options in a matter of seconds, according to the insurer.
Cedars-Sinai oncology clinicians, for instance, will help develop recommendations for appropriate clinical content. They will develop hypothetical scenarios, evaluate treatment options provided by the Watson technology, and provide guidance on improving the information and utility of options provided to physicians.
William Audeh, M.D., medical director at the cancer institute, will lead the work. WellPoint expects its first pilot projects to start in 2012.
Be the first to comment on this post using the section below.